Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Testosterone may slow down wound healing and increase inflammation.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride slows down motherly behavior in first-time pregnant rats.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.